This month’s Ophthalmology, the journal of the American Academy of Ophthalmology, includes new studies on links between eye diseases and two widely-prescribed drugs: SSRI (selective serotonin reuptake inhibitor) antidepressants, and amantadine, a Parkinson’s disease treatment. Some Antidepressants May Bump Up Cataract Risk Seniors who take SSRI antidepressants may be more likely to develop cataracts , says the first major study to examine this interaction…

View post: 
Antidepressants Linked To Cataract Risk; Parkinson’s Drug May Cause Corneal Damage

You may also like:

• Statement From The American Academy Of Ophthalmology Regarding "Vodka Eyeballing"
• Night Time Eating Linked To Tooth Loss
• Blogs Comment On Anniversary Of Tiller’s Death, Ultrasound Laws, Other Topics
• Mexican Supreme Court Upholds Law Permitting Emergency Contraception For Rape Survivors
• Cataract Risk From Antidepressants - Parkinson’s Drug May Cause Corneal Damage
• High Earners Seem To Run Double The Risk Of Retinal Detachment
• FDA Designates Fast Track Status For Apaziquone (EOquin(R)) For Bladder Cancer
• Men Hit By ‘Inexplicable’ Greater Cancer Death Risk
• Los Angeles County Health Officials Release Report On HIV In Adult Film Industry
• Delaware Bill Would Allow All Parents To Enroll Children In State-Sponsored Health Plan